IRIS

1.1 Articolo in rivista: [27918] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 8.861 a 8.880 di 27.918
Titolo Data di pubblicazione Autore(i) File
Role of gemcitabine in ovarian cancer treatment 1-gen-2006 Lorusso, D; Di Stefano, A.; Fanfani, F.; Scambia, G.
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer - A Multicentre Italian Trial in Ovarian cancer (MITO-5) study 1-gen-2008 Pignata, Sandro; Breda, Enrico; Scambia, Giovanni; Pisano, Carmela; Zagonel, Vittorina; Lorusso, D; Greggi, Stefano; De Vivo, Rocco; Ferrandina, Gabriella; Gallo, Ciro; Perrone, Francesco
Is this efficacy in partially platinum-sensitive patients observed at any relapse? 1-gen-2013 Sehouli, J; del Campo, Jm; Lorusso, D
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms 1-gen-2019 Harter, P; Sehouli, J; Lorusso, D; Reuss, A; Vergote, I; Marth, C; Kim, Jw; Raspagliesi, F; Lampe, B; Aletti, G; Meier, W; Cibula, D; Mustea, A; Mahner, S; Runnebaum, Ib; Schmalfeldt, B; Burges, A; Kimmig, R; Scambia, G; Greggi, S; Hilpert, F; Hasenburg, A; Hillemanns, P; Giorda, G; von Leffern, I; Schade-Brittinger, C; Wagner, U; du Bois, A.
Surgical Management and Prognostic Factors of Vulvovaginal Melanoma 1-gen-2016 Ditto, A; Bogani, G; Martinelli, F; Di Donato, V; Laufer, J; Scasso, S; Chiappa, V; Signorelli, M; Indini, A; Lorusso, D; Raspagliesi, F
Surgical Treatment of Recurrent Endometrial Cancer: Time for a Paradigm Shift 1-gen-2015 Papadia, A; Bellati, F; Ditto, A; Bogani, G; Gasparri, Ml; Di Donato, V; Martinelli, F; Lorusso, D; Benedetti-Panici, P; Raspagliesi, F
Invasive Paget Disease of the Vulva. 1-gen-2018 Borghi, C; Bogani, G; Ditto, A; Martinelli, F; Signorelli, M; Chiappa, V; Scaffa, C; Perotto, S; Leone Roberti Maggiore, U; Recalcati, D; Lorusso, D; Raspagliesi, F.
Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: Association with pathological response to treatment and clinical outcome 1-gen-2006 Ferrandina, Gabriella; Distefano, Mariagrazia; Smaniotto, Daniela; Morganti, Alessio; Paglia, Amelia; Macchia, Gabriella; Corvari, Barbara; Lorusso, D; Scambia, Giovanni; RI Macchia, Gabriella/H-2987-2012
Human papillomavirus (HPV) persistence and HPV 31 predict the risk of recurrence in high-grade vaginal intraepithelial neoplasia. 1-gen-2017 Bogani, G; Martinelli, F; Ditto, A; Taverna, F; Lombardo, C; Signorelli, M; Chiappa, V; Leone Roberti Maggiore, U; Fontanella, C; Sabatucci, I; Borghi, C; Recalcati, D; Indini, A; Lorusso, D; Raspagliesi, F.
Phase II study of pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients - May a new treatment schedule improve toxicity profile? 1-gen-2004 Lorusso, D; Naldini, A; Testa, A; D'Agostino, G; Scambia, G; Ferrandina, G
Advanced ovarian cancer: Omental bursa, lesser omentum, celiac, portal and triad nodes spread as cause of inaccurate evaluation of residual tumor 1-gen-2013 Raspagliesi, F; Ditto, A; Martinelli, F; Haeusler, E; Lorusso, D
Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience 1-gen-2019 Indini, A; Di Guardo, L; Cimminiello, C; Lorusso, D; Raspagliesi, F; Del Vecchio, M.
Fertility sparing surgery in early stage epithelial ovarian cancer 1-gen-2014 Ditto, A; Martinelli, F; Lorusso, D; Haeusler, E; Carcangiu, M; Raspagliesi, F
Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer 1-gen-2019 Lorusso, D; Hilpert, F; González Martin, A; Rau, J; Ottevanger, P; Greimel, E; Lück, Hj; Selle, F; Colombo, N; Kroep, Jr; Mirza, Mr; Berger, R; Pardo, B; Grischke, Em; Berton-Rigaud, D; Martinez-Garcia, J; Vergote, I; Redondo, A; Cardona, A; Bastière-Truchot, L; du Bois, A; Kurzeder, C; PENELOPE trial, Investigators.
What do you usually do in your hospital when a patient develops hypersensitivity to platinum? 1-gen-2013 del Campo, Jm; Sehouli, J; Lorusso, D
Gemcitabine (GEM) and pegylated liposomal doxorubicin (PLD) in recurrent metastatic breast carcinoma: A phase II study 1-gen-2005 Ferrandina, G.; Adamo, V.; Ferrau, F.; Condemi, G.; Di Lullo, L.; Rossello, R.; Lorusso, D; Garipoli, C.; Scambia, G.
Topotecan and gemcitabine in platinum/paclitaxel-resistant ovarian cancer 1-gen-2001 Greggi, S; Salerno, Mg; D'Agostino, G; Ferrandina, G; Lorusso, D; Manzione, L; Mancuso, S; Scambia, G
Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial 1-gen-2019 Lorusso, D; Ferrandina, G; Colombo, N; Pignata, S; Pietragalla, A; Sonetto, C; Pisano, C; Lapresa, Mt; Savarese, A; Tagliaferri, P; Lombardi, D; Cinieri, S; Breda, E; Sabatucci, I; Sabbatini, R; Conte, C; Cecere, Sc; Maltese, G; Scambia, G.
Introducing nerve-sparing approach during minimally invasive radical hysterectomy for locally-advanced cervical cancer: A multi-institutional experience 1-gen-2017 Raspagliesi, F; Bogani, G; Spinillo, A; Ditto, A; Bogliolo, S; Casarin, J; Leone Roberti Maggiore, U; Martinelli, F; Signorelli, M; Gardella, B; Chiappa, V; Scaffa, C; Ferrero, S; Cromi, A; Lorusso, D; Ghezzi, F.
The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma 1-gen-2020 Colombo, N; Oza, Am; Lorusso, D; Aghajanian, C; Oaknin, A; Dean, A; Weberpals, Ji; Clamp, Ar; Scambia, G; Leary, A; Holloway, Rw; Gancedo Margarita, A; Fong, Pc; Goh, Jc; O'Malley, Dm; Armstrong, Dk; Banerjee, S; García-Donas, J; Swisher, Em; Meunier, J; Cameron, T; Maloney, L; Goble, S; Bedel, J; Ledermann, Ja; Coleman, Rl
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 8.861 a 8.880 di 27.918
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista27918
Autore
  • Oyen, Willem Jozef Gerard891
  • SANTORO, Armando806
  • CANONICA, Giorgio775
  • Repici, Alessandro717
  • DANESE, Silvio643
  • Hassan, Cesare590
  • Indolfi, Ciro471
  • Marcacci, Maurilio467
  • Fasano, Alfonso465
  • D' Incalci, Maurizio454
Data di pubblicazione
  • In corso di stampa14
  • 2020 - 20269653
  • 2010 - 201911835
  • 2000 - 20094579
  • 1990 - 19991485
  • 1980 - 1989329
  • 1975 - 197923
Editore
  • Edition AERCV1
  • Elsevier1
  • Futura Publishing Company1
  • Grafica Luigi Monti s.r.l.1
  • Karger, Basel1
  • Mosby1
  • sn1
  • Springer-Verlag1
  • Thieme1
Rivista
  • DIGESTIVE AND LIVER DISEASE372
  • EUROPEAN JOURNAL OF NUCLEAR MEDIC...267
  • ANNALS OF ONCOLOGY244
  • CANCERS232
  • PLOS ONE223
  • THE JOURNAL OF NUCLEAR MEDICINE222
  • JOURNAL OF CLINICAL MEDICINE215
  • EUROPEAN JOURNAL OF CANCER205
  • GASTROINTESTINAL ENDOSCOPY197
  • ALLERGY180
Keyword
  • Humans2166
  • Female1035
  • Male996
  • Middle Aged767
  • Aged669
  • Adult559
  • COVID-19442
  • Treatment Outcome373
  • Animals329
  • Retrospective Studies264
Lingua
  • eng19972
  • ita459
  • spa14
  • fre11
  • ger8
  • enm4
  • por2
  • chi1
Accesso al fulltext
  • no fulltext25665
  • reserved1362
  • open891